Literature DB >> 10792444

Expression of novel antioxidant thioredoxin-2 in the rat brain.

E Rybnikova1, A E Damdimopoulos, J A Gustafsson, G Spyrou, M Pelto-Huikko.   

Abstract

Thioredoxins are a class of small redox-regulating proteins that have been implicated in the control of various aspects of cellular functions and seem to be one of the key regulators of signalling in the cellular responses to various stresses. Thioredoxin-2 (Trx2) is a novel mammalian thioredoxin which, in contrast to previously known cytosolic thioredoxin (Trx1), has been localized to the mitochondria. Trx2 is abundantly expressed in skeletal muscle, heart and adrenal gland, as well as in some other peripheral tissues with high metabolic activity. Using in situ hybridization and immunohistochemistry, we have studied the distribution and regulation of Trx2 expression in the rat brain. Trx2 mRNA and protein are highly expressed in the neurons in several brain regions, including the olfactory bulb, frontal cortex, hippocampus, some hypothalamic and thalamic nuclei, cerebellum and numerous brainstem nuclei. In addition, the Trx2 mRNA expression in paraventricular hypothalamic nucleus and reticular thalamic nucleus was found to be sensitive to peripheral glucocorticoids, as dexamethasone treatment caused significant elevation of Trx2 mRNA level in this area. No changes in other brain areas were observed after dexamethasone treatment. These findings implicate a significant regulatory and/or protective function of Trx2 in the nervous system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10792444     DOI: 10.1046/j.1460-9568.2000.00059.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  13 in total

1.  The mitochondrial antioxidants thioredoxin-2 and Mn-superoxide dismutase are involved in the mechanisms of brain hypoxic tolerance.

Authors:  M O Samoilov; E A Rybnikova; E I Tjulkova; G Spyrou; M Pelto-Huikko
Journal:  Dokl Biol Sci       Date:  2002 Nov-Dec

Review 2.  Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease.

Authors:  Aracely Garcia-Garcia; Laura Zavala-Flores; Humberto Rodriguez-Rocha; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2012-05-03       Impact factor: 8.401

Review 3.  Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes.

Authors:  Vittorio Calabrese; Eleonora Guagliano; Maria Sapienza; Mariangela Panebianco; Stella Calafato; Edoardo Puleo; Giovanni Pennisi; Cesare Mancuso; D Allan Butterfield; Annamaria Giuffrida Stella
Journal:  Neurochem Res       Date:  2006-12-27       Impact factor: 3.996

Review 4.  Mitochondrial mechanisms of redox cycling agents implicated in Parkinson's disease.

Authors:  Pamela Lopert; Manisha Patel
Journal:  J Neural Transm (Vienna)       Date:  2015-03-07       Impact factor: 3.575

Review 5.  Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection.

Authors:  Meijuan Zhang; Chengrui An; Yanqin Gao; Rehana K Leak; Jun Chen; Feng Zhang
Journal:  Prog Neurobiol       Date:  2012-09-29       Impact factor: 11.685

6.  Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury.

Authors:  Amadou K S Camara; Martin Bienengraeber; David F Stowe
Journal:  Front Physiol       Date:  2011-04-12       Impact factor: 4.566

7.  Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis.

Authors:  Toru Tanaka; Fumihito Hosoi; Yuko Yamaguchi-Iwai; Hajime Nakamura; Hiroshi Masutani; Shugo Ueda; Akira Nishiyama; Shunichi Takeda; Hiromi Wada; Giannis Spyrou; Junji Yodoi
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

Review 8.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

9.  Sex- and structure-specific differences in antioxidant responses to methylmercury during early development.

Authors:  Joanna A Ruszkiewicz; Aaron B Bowman; Marcelo Farina; João B T Rocha; Michael Aschner
Journal:  Neurotoxicology       Date:  2016-07-22       Impact factor: 4.294

Review 10.  Thioredoxin-Interacting Protein (TXNIP) in Cerebrovascular and Neurodegenerative Diseases: Regulation and Implication.

Authors:  Sanaz Nasoohi; Saifudeen Ismael; Tauheed Ishrat
Journal:  Mol Neurobiol       Date:  2018-02-27       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.